Elevated lipoprotein (a) levels in hypertensive patients in southern part of Nigeriadoi:10.55131/jphd/2024/220219Eguvbe, Augustine OnovuakpoOlogbo, Thompson OnoriedeodeOfili, Ufuoma BlessingOghenekaro, Ekata AgnesJournal of Public Health & Development...
lipoprotein(a)cardiac arrhythmiaatrial fibrillationpreventionatherosclerosisand risk factorsAIMS. Atrial fibrillation (AF) is the most common cardiac arrhythmia. Although lipoprotein(a) [Lp(a)] is known to be a well-established risk factor for atherosclerotic cardiovascular disease (ASCVD), its role in...
That serum Lp(a) levels are significantly elevated in dialysis and renal transplantation patients suggests at least 1 common pathogenic mechanism for the high incidence of atherosclerosis in both groups. Keywords: Lipoprotein(a), Hyperlipidemia, Atherosclerosis, Renal transplantation, Hemodialysis This ...
Elevated plasma levels of total cholesterol and increase in the hepatic synthesis of some apo B-containing lipoproteins have been noted in the nephrotic syndrome. Apoprotein (a), the apolipoprotein distinguishing lipoprotein (a) [Lp(a)] from low-density lipoprotein, is equally of hepatic origin, ...
A Capurso,F Resta,AM Colacicco,E Vespertino,V Solfrizzi 摘要: L-carnitine is an amino acid involved in the mechanism by which fatty acids are transported through the mitochondrial wall for oxidation. To determine whether the in vivo metabolism of lipoprotein(a) (Lp[a]) is linked to intra...
In the Copenhagen City Heart Study, risk estimates for high levels of lipoprotein(a) were in the same direction but did not reach statistical significance. Conclusions In a large contemporary general population study, high plasma levels of lipoprotein(a) were associated with increased risk of ...
Lipoprotein(a) (Lp[a]) is a particle consisting of a low-density lipoprotein (LDL)-like core attached to an apolipoprotein(a) chain. Apolipoprotein(a) size is inversely related to circulating Lp(a) concentration, and Lp(a) levels are up to 90% heritable with most of the variance explaine...
Lipoprotein apheresis (LA) is a therapeutic option for hyperlipoproteinemia(a) (hyper-Lp(a)) and atherosclerotic cardiovascular disease (ASCVD). LA improves blood rheology, reduces oxidative stress parameters and improves endothelial function. The underlying molecular mechanisms of LA beneficial effects ...
Elevated lipoprotein(a) levels and small apo(a) isoforms are compatible with longevity: evidence from a large population of French centenarians. Epidemiological studies have shown lipoprotein(a) (Lp(a)) to be an independent risk factor for cardiovascular disease. Lp(a) is a cholesterol-rich, low...
Elevated lipoprotein(a) (Lp(a)) is an inherited lipid disorder and an independent risk factor for cardiovascular (CV) disease. Although its prevalence in the general population has been well-documented, the prevalence of elevated Lp(a) in patients with clinical coronary artery disease (CAD) is...